Stanek E J, Nara A R, Strohl K P, Nair R N, Decker M J, Munger M A
Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy and Science, PA 19104.
Pharmacotherapy. 1994 May-Jun;14(3):321-9.
To evaluate the effects of angiotensin-converting enzyme (ACE) inhibition on continuous pulse oximetry recordings of arterial oxygen saturation (SpO2).
Open-label study.
Cardiology clinics at two large teaching hospitals.
Eight patients with New York Heart Association Functional Class (NYHA FC) II-III heart failure.
Patients were studied after an ACE inhibitor washout (baseline, B), and after 3 months following resumption of therapy (ACE).
Monitoring times for B and ACEI were approximately 22 hours. Reduction trends were observed for number (190 +/- 170 vs 125 +/- 67 B vs ACEI), magnitude (8.2 +/- 1.4% vs 7.5 +/- 1.8%), and duration (2.45 +/- 2.8 vs 1.35 +/- 0.8 min) of desaturations/monitoring period, and for nadir SpO2/desaturation (88.1 +/- 1.5% vs 89.9 +/- 3.3%). The B desaturation index [(cumulative desaturation time/monitoring period time) x 100, a measure of hypoxic stress or burden] decreased from 19.4 +/- 8.1% to 11.9 +/- 8.1% at ACEI (p = 0.024).
Long-term ACE inhibitor therapy improves the profile of SpO2 values over time in patients with NYHA FC II-III heart failure.
评估血管紧张素转换酶(ACE)抑制对动脉血氧饱和度(SpO2)连续脉搏血氧饱和度记录的影响。
开放标签研究。
两家大型教学医院的心脏病诊所。
8例纽约心脏协会功能分级(NYHA FC)II - III级心力衰竭患者。
患者在停用ACE抑制剂后(基线,B)以及恢复治疗3个月后(ACE)接受研究。
B期和ACEI期的监测时间约为22小时。观察到每监测期的血氧饱和度下降次数(190±170次对125±67次,B期对ACEI期)、下降幅度(8.2±1.4%对7.5±1.8%)和持续时间(2.45±2.8分钟对1.35±0.8分钟)以及最低SpO2/血氧饱和度下降情况(88.1±1.5%对89.9±3.3%)均呈下降趋势。B期的血氧饱和度下降指数[(累积血氧饱和度下降时间/监测期时间)×100,衡量缺氧应激或负担的指标]在ACEI期从19.4±8.1%降至11.9±8.1%(p = 0.024)。
长期ACE抑制剂治疗可改善NYHA FC II - III级心力衰竭患者随时间变化的SpO2值情况。